---
figid: PMC3398461__nihms386791f2
figlink: /pmc/articles/PMC3398461/figure/F2/
number: Figure 2
caption: Possible models of oncogenicity. In model 1, genetic alterations in any of
  the PI3K pathway members lead to amplification of PI3K signaling. In model 2, alterations
  of RTKs, RAS or PTEN in addition to mutant PIK3CA lead to activation of non-overlapping
  pathways or disrupt negative feedback loops to enhance PI3K signaling. In model
  3, oncogenic RAS leads to tumorigenesis via a mechanism independent of PI3K. In
  model 4, loss of PTEN leads to p53-dependent cellular senescence, which may be overcome
  by acquisition of an additional mutation in the pathway. In model 5, activation
  of PI3K is enhanced through interactions with oncogenic RAS. PI3K, phosphoinositide
  3-kinase; RTKs, receptor tyrosine kinases.
pmcid: PMC3398461
papertitle: 'PI3K pathway alterations in cancer: variations on a theme.'
reftext: TL Yuan, et al. Oncogene. ;27(41):5497-5510.
pmc_ranked_result_index: '13048'
pathway_score: 0.9517105
filename: nihms386791f2.jpg
figtitle: Possible models of oncogenicity
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3398461__nihms386791f2.html
  '@type': Dataset
  description: Possible models of oncogenicity. In model 1, genetic alterations in
    any of the PI3K pathway members lead to amplification of PI3K signaling. In model
    2, alterations of RTKs, RAS or PTEN in addition to mutant PIK3CA lead to activation
    of non-overlapping pathways or disrupt negative feedback loops to enhance PI3K
    signaling. In model 3, oncogenic RAS leads to tumorigenesis via a mechanism independent
    of PI3K. In model 4, loss of PTEN leads to p53-dependent cellular senescence,
    which may be overcome by acquisition of an additional mutation in the pathway.
    In model 5, activation of PI3K is enhanced through interactions with oncogenic
    RAS. PI3K, phosphoinositide 3-kinase; RTKs, receptor tyrosine kinases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - PIK3R6
  - HRAS
  - PIK3R5
  - NRAS
  - PIK3CA
  - KRAS
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - AKT3
  - PIK3R4
  - PTEN
  - PIK3R3
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals: []
diseases: []
---
